Facial Nerve Schwannomas: Review of 80 Cases Over 25 Years at Mayo Clinic
Abstract Objective To elucidate the long-term clinical behavior, treatment, and outcomes of sporadic facial nerve schwannoma (FNS) in a large cohort of patients managed in the post–magnetic resonance imaging era. Patients and Methods Retrospective review at a single tertiary health care system (Janu...
Gespeichert in:
| Veröffentlicht in: | Mayo Clinic proceedings 2016-11, Vol.91 (11), p.1563-1576 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1576 |
|---|---|
| container_issue | 11 |
| container_start_page | 1563 |
| container_title | Mayo Clinic proceedings |
| container_volume | 91 |
| creator | Carlson, Matthew L., MD Deep, Nicholas L., MD Patel, Neil S., MD Lundy, Larry B., MD Tombers, Nicole M., RN Lohse, Christine M., MS Link, Michael J., MD Driscoll, Colin L., MD |
| description | Abstract Objective To elucidate the long-term clinical behavior, treatment, and outcomes of sporadic facial nerve schwannoma (FNS) in a large cohort of patients managed in the post–magnetic resonance imaging era. Patients and Methods Retrospective review at a single tertiary health care system (January 1, 1990, through December 31, 2015), evaluating 80 consecutive patients with sporadic FNS. Results Ninety-eight patients with FNS were identified; 10 with incomplete data and 8 with neurofibromatosis type 2 were excluded. The remaining 80 patients (median age, 47 years; 58% women) were analyzed. Forty-three (54%) patients presented with asymmetrical hearing loss, 33 (41%) reported facial paresis, and 21 (26%) reported facial spasm. Seventeen (21%) exhibited radiologic features mimicking vestibular schwannoma, 14 (18%) presented as a parotid mass, and 5 (6%) were discovered incidentally. Factors predictive of facial nerve paresis or spasm before treatment were female sex and tumor involvement of the labyrinthine/geniculate and tympanic facial nerve segments. The median growth rate among growing FNS was 2.0 mm/y. Details regarding clinical outcome according to treatment modality are described. Conclusion In patients with FNS, female sex and involvement of the labyrinthine/geniculate and tympanic segments of the facial nerve predict a higher probability of facial paresis or spasm. When isolated to the posterior fossa or parotid gland, establishing a preoperative diagnosis of FNS is challenging. Treatment should be tailored according to tumor location and size, existing facial nerve function, patient priorities, and age. A management algorithm is presented, prioritizing long-term facial nerve function. |
| doi_str_mv | 10.1016/j.mayocp.2016.07.007 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835400284</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A472436773</galeid><els_id>1_s2_0_S0025619616304062</els_id><sourcerecordid>A472436773</sourcerecordid><originalsourceid>FETCH-LOGICAL-c581t-cc6771069ec2f798829fb3f3800622d5b69ca1c8f2695c8c58bdc613d4562a03</originalsourceid><addsrcrecordid>eNqFkk9v1DAQxS0EotvCN0DIEhLikmA7tpNwQKpWFCoVKtFeOFneyYT1ksRbO7vVfvs6pPzrBflg2fq98fO8IeQFZzlnXL_d5L09eNjmIp1yVuaMlY_IgtdSZEpJ_ZgsGBMq07zWR-Q4xg1LRF3Lp-RIlKVggrEFOT-z4GxHv2DYI72C9a0dBt_b-I5-xb3DW-pbWjG6tBEjvdxjoELRb2hDpHakn5MFuuzc4OAZedLaLuLz-_2EXJ99uF5-yi4uP54vTy8yUBUfMwBdlpzpGkG0ZV1Vom5XRVtUjGkhGrXSNVgOVSt0raBKolUDmheNVFpYVpyQN3PZbfA3O4yj6V0E7Do7oN9Fw6tCyfTxSib01QN043dhSOYmquRKKzlR-Ux9tx0aN7R-DBbSarB34AdsXbo_laWQRbJeJMHrvwRrtN24jr7bjc4P8V9QziAEH2PA1myD6204GM7MlKHZmDlDM2VoWGlSQkn28t72btVj81v0K7QEvJ8BTG1OGQUTweEA2LiAMJrGu_-98LAA_IzQdj_wgPFPl0wUhpmraY6mMeK6YDLFVNwBua--dQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1837156544</pqid></control><display><type>article</type><title>Facial Nerve Schwannomas: Review of 80 Cases Over 25 Years at Mayo Clinic</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Carlson, Matthew L., MD ; Deep, Nicholas L., MD ; Patel, Neil S., MD ; Lundy, Larry B., MD ; Tombers, Nicole M., RN ; Lohse, Christine M., MS ; Link, Michael J., MD ; Driscoll, Colin L., MD</creator><creatorcontrib>Carlson, Matthew L., MD ; Deep, Nicholas L., MD ; Patel, Neil S., MD ; Lundy, Larry B., MD ; Tombers, Nicole M., RN ; Lohse, Christine M., MS ; Link, Michael J., MD ; Driscoll, Colin L., MD</creatorcontrib><description>Abstract Objective To elucidate the long-term clinical behavior, treatment, and outcomes of sporadic facial nerve schwannoma (FNS) in a large cohort of patients managed in the post–magnetic resonance imaging era. Patients and Methods Retrospective review at a single tertiary health care system (January 1, 1990, through December 31, 2015), evaluating 80 consecutive patients with sporadic FNS. Results Ninety-eight patients with FNS were identified; 10 with incomplete data and 8 with neurofibromatosis type 2 were excluded. The remaining 80 patients (median age, 47 years; 58% women) were analyzed. Forty-three (54%) patients presented with asymmetrical hearing loss, 33 (41%) reported facial paresis, and 21 (26%) reported facial spasm. Seventeen (21%) exhibited radiologic features mimicking vestibular schwannoma, 14 (18%) presented as a parotid mass, and 5 (6%) were discovered incidentally. Factors predictive of facial nerve paresis or spasm before treatment were female sex and tumor involvement of the labyrinthine/geniculate and tympanic facial nerve segments. The median growth rate among growing FNS was 2.0 mm/y. Details regarding clinical outcome according to treatment modality are described. Conclusion In patients with FNS, female sex and involvement of the labyrinthine/geniculate and tympanic segments of the facial nerve predict a higher probability of facial paresis or spasm. When isolated to the posterior fossa or parotid gland, establishing a preoperative diagnosis of FNS is challenging. Treatment should be tailored according to tumor location and size, existing facial nerve function, patient priorities, and age. A management algorithm is presented, prioritizing long-term facial nerve function.</description><identifier>ISSN: 0025-6196</identifier><identifier>EISSN: 1942-5546</identifier><identifier>DOI: 10.1016/j.mayocp.2016.07.007</identifier><identifier>PMID: 27720200</identifier><identifier>CODEN: MACPAJ</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Cranial Nerve Neoplasms - diagnosis ; Cranial Nerve Neoplasms - therapy ; Diagnosis, Differential ; Dizziness - etiology ; Facial Nerve Diseases - diagnosis ; Facial Nerve Diseases - therapy ; Facial Paralysis - etiology ; Female ; Headache - etiology ; Hearing Loss - etiology ; Hemifacial Spasm - etiology ; Humans ; Incidental Findings ; Internal Medicine ; Male ; Middle Aged ; Minnesota ; Neurilemmoma - diagnosis ; Neurilemmoma - therapy ; Paralysis ; Patient Outcome Assessment ; Retrospective Studies ; Schwann cells ; Tinnitus - etiology ; Young Adult</subject><ispartof>Mayo Clinic proceedings, 2016-11, Vol.91 (11), p.1563-1576</ispartof><rights>Mayo Foundation for Medical Education and Research</rights><rights>2016 Mayo Foundation for Medical Education and Research</rights><rights>Copyright © 2016 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.</rights><rights>COPYRIGHT 2016 Frontline Medical Communications Inc.</rights><rights>Copyright Mayo Foundation for Medical Education and Research Nov 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c581t-cc6771069ec2f798829fb3f3800622d5b69ca1c8f2695c8c58bdc613d4562a03</citedby><cites>FETCH-LOGICAL-c581t-cc6771069ec2f798829fb3f3800622d5b69ca1c8f2695c8c58bdc613d4562a03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27720200$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carlson, Matthew L., MD</creatorcontrib><creatorcontrib>Deep, Nicholas L., MD</creatorcontrib><creatorcontrib>Patel, Neil S., MD</creatorcontrib><creatorcontrib>Lundy, Larry B., MD</creatorcontrib><creatorcontrib>Tombers, Nicole M., RN</creatorcontrib><creatorcontrib>Lohse, Christine M., MS</creatorcontrib><creatorcontrib>Link, Michael J., MD</creatorcontrib><creatorcontrib>Driscoll, Colin L., MD</creatorcontrib><title>Facial Nerve Schwannomas: Review of 80 Cases Over 25 Years at Mayo Clinic</title><title>Mayo Clinic proceedings</title><addtitle>Mayo Clin Proc</addtitle><description>Abstract Objective To elucidate the long-term clinical behavior, treatment, and outcomes of sporadic facial nerve schwannoma (FNS) in a large cohort of patients managed in the post–magnetic resonance imaging era. Patients and Methods Retrospective review at a single tertiary health care system (January 1, 1990, through December 31, 2015), evaluating 80 consecutive patients with sporadic FNS. Results Ninety-eight patients with FNS were identified; 10 with incomplete data and 8 with neurofibromatosis type 2 were excluded. The remaining 80 patients (median age, 47 years; 58% women) were analyzed. Forty-three (54%) patients presented with asymmetrical hearing loss, 33 (41%) reported facial paresis, and 21 (26%) reported facial spasm. Seventeen (21%) exhibited radiologic features mimicking vestibular schwannoma, 14 (18%) presented as a parotid mass, and 5 (6%) were discovered incidentally. Factors predictive of facial nerve paresis or spasm before treatment were female sex and tumor involvement of the labyrinthine/geniculate and tympanic facial nerve segments. The median growth rate among growing FNS was 2.0 mm/y. Details regarding clinical outcome according to treatment modality are described. Conclusion In patients with FNS, female sex and involvement of the labyrinthine/geniculate and tympanic segments of the facial nerve predict a higher probability of facial paresis or spasm. When isolated to the posterior fossa or parotid gland, establishing a preoperative diagnosis of FNS is challenging. Treatment should be tailored according to tumor location and size, existing facial nerve function, patient priorities, and age. A management algorithm is presented, prioritizing long-term facial nerve function.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cranial Nerve Neoplasms - diagnosis</subject><subject>Cranial Nerve Neoplasms - therapy</subject><subject>Diagnosis, Differential</subject><subject>Dizziness - etiology</subject><subject>Facial Nerve Diseases - diagnosis</subject><subject>Facial Nerve Diseases - therapy</subject><subject>Facial Paralysis - etiology</subject><subject>Female</subject><subject>Headache - etiology</subject><subject>Hearing Loss - etiology</subject><subject>Hemifacial Spasm - etiology</subject><subject>Humans</subject><subject>Incidental Findings</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Minnesota</subject><subject>Neurilemmoma - diagnosis</subject><subject>Neurilemmoma - therapy</subject><subject>Paralysis</subject><subject>Patient Outcome Assessment</subject><subject>Retrospective Studies</subject><subject>Schwann cells</subject><subject>Tinnitus - etiology</subject><subject>Young Adult</subject><issn>0025-6196</issn><issn>1942-5546</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkk9v1DAQxS0EotvCN0DIEhLikmA7tpNwQKpWFCoVKtFeOFneyYT1ksRbO7vVfvs6pPzrBflg2fq98fO8IeQFZzlnXL_d5L09eNjmIp1yVuaMlY_IgtdSZEpJ_ZgsGBMq07zWR-Q4xg1LRF3Lp-RIlKVggrEFOT-z4GxHv2DYI72C9a0dBt_b-I5-xb3DW-pbWjG6tBEjvdxjoELRb2hDpHakn5MFuuzc4OAZedLaLuLz-_2EXJ99uF5-yi4uP54vTy8yUBUfMwBdlpzpGkG0ZV1Vom5XRVtUjGkhGrXSNVgOVSt0raBKolUDmheNVFpYVpyQN3PZbfA3O4yj6V0E7Do7oN9Fw6tCyfTxSib01QN043dhSOYmquRKKzlR-Ux9tx0aN7R-DBbSarB34AdsXbo_laWQRbJeJMHrvwRrtN24jr7bjc4P8V9QziAEH2PA1myD6204GM7MlKHZmDlDM2VoWGlSQkn28t72btVj81v0K7QEvJ8BTG1OGQUTweEA2LiAMJrGu_-98LAA_IzQdj_wgPFPl0wUhpmraY6mMeK6YDLFVNwBua--dQ</recordid><startdate>20161101</startdate><enddate>20161101</enddate><creator>Carlson, Matthew L., MD</creator><creator>Deep, Nicholas L., MD</creator><creator>Patel, Neil S., MD</creator><creator>Lundy, Larry B., MD</creator><creator>Tombers, Nicole M., RN</creator><creator>Lohse, Christine M., MS</creator><creator>Link, Michael J., MD</creator><creator>Driscoll, Colin L., MD</creator><general>Elsevier Inc</general><general>Frontline Medical Communications Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4U-</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20161101</creationdate><title>Facial Nerve Schwannomas: Review of 80 Cases Over 25 Years at Mayo Clinic</title><author>Carlson, Matthew L., MD ; Deep, Nicholas L., MD ; Patel, Neil S., MD ; Lundy, Larry B., MD ; Tombers, Nicole M., RN ; Lohse, Christine M., MS ; Link, Michael J., MD ; Driscoll, Colin L., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c581t-cc6771069ec2f798829fb3f3800622d5b69ca1c8f2695c8c58bdc613d4562a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cranial Nerve Neoplasms - diagnosis</topic><topic>Cranial Nerve Neoplasms - therapy</topic><topic>Diagnosis, Differential</topic><topic>Dizziness - etiology</topic><topic>Facial Nerve Diseases - diagnosis</topic><topic>Facial Nerve Diseases - therapy</topic><topic>Facial Paralysis - etiology</topic><topic>Female</topic><topic>Headache - etiology</topic><topic>Hearing Loss - etiology</topic><topic>Hemifacial Spasm - etiology</topic><topic>Humans</topic><topic>Incidental Findings</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Minnesota</topic><topic>Neurilemmoma - diagnosis</topic><topic>Neurilemmoma - therapy</topic><topic>Paralysis</topic><topic>Patient Outcome Assessment</topic><topic>Retrospective Studies</topic><topic>Schwann cells</topic><topic>Tinnitus - etiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carlson, Matthew L., MD</creatorcontrib><creatorcontrib>Deep, Nicholas L., MD</creatorcontrib><creatorcontrib>Patel, Neil S., MD</creatorcontrib><creatorcontrib>Lundy, Larry B., MD</creatorcontrib><creatorcontrib>Tombers, Nicole M., RN</creatorcontrib><creatorcontrib>Lohse, Christine M., MS</creatorcontrib><creatorcontrib>Link, Michael J., MD</creatorcontrib><creatorcontrib>Driscoll, Colin L., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>University Readers</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Mayo Clinic proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carlson, Matthew L., MD</au><au>Deep, Nicholas L., MD</au><au>Patel, Neil S., MD</au><au>Lundy, Larry B., MD</au><au>Tombers, Nicole M., RN</au><au>Lohse, Christine M., MS</au><au>Link, Michael J., MD</au><au>Driscoll, Colin L., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Facial Nerve Schwannomas: Review of 80 Cases Over 25 Years at Mayo Clinic</atitle><jtitle>Mayo Clinic proceedings</jtitle><addtitle>Mayo Clin Proc</addtitle><date>2016-11-01</date><risdate>2016</risdate><volume>91</volume><issue>11</issue><spage>1563</spage><epage>1576</epage><pages>1563-1576</pages><issn>0025-6196</issn><eissn>1942-5546</eissn><coden>MACPAJ</coden><abstract>Abstract Objective To elucidate the long-term clinical behavior, treatment, and outcomes of sporadic facial nerve schwannoma (FNS) in a large cohort of patients managed in the post–magnetic resonance imaging era. Patients and Methods Retrospective review at a single tertiary health care system (January 1, 1990, through December 31, 2015), evaluating 80 consecutive patients with sporadic FNS. Results Ninety-eight patients with FNS were identified; 10 with incomplete data and 8 with neurofibromatosis type 2 were excluded. The remaining 80 patients (median age, 47 years; 58% women) were analyzed. Forty-three (54%) patients presented with asymmetrical hearing loss, 33 (41%) reported facial paresis, and 21 (26%) reported facial spasm. Seventeen (21%) exhibited radiologic features mimicking vestibular schwannoma, 14 (18%) presented as a parotid mass, and 5 (6%) were discovered incidentally. Factors predictive of facial nerve paresis or spasm before treatment were female sex and tumor involvement of the labyrinthine/geniculate and tympanic facial nerve segments. The median growth rate among growing FNS was 2.0 mm/y. Details regarding clinical outcome according to treatment modality are described. Conclusion In patients with FNS, female sex and involvement of the labyrinthine/geniculate and tympanic segments of the facial nerve predict a higher probability of facial paresis or spasm. When isolated to the posterior fossa or parotid gland, establishing a preoperative diagnosis of FNS is challenging. Treatment should be tailored according to tumor location and size, existing facial nerve function, patient priorities, and age. A management algorithm is presented, prioritizing long-term facial nerve function.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>27720200</pmid><doi>10.1016/j.mayocp.2016.07.007</doi><tpages>14</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0025-6196 |
| ispartof | Mayo Clinic proceedings, 2016-11, Vol.91 (11), p.1563-1576 |
| issn | 0025-6196 1942-5546 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1835400284 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Adolescent Adult Aged Aged, 80 and over Cranial Nerve Neoplasms - diagnosis Cranial Nerve Neoplasms - therapy Diagnosis, Differential Dizziness - etiology Facial Nerve Diseases - diagnosis Facial Nerve Diseases - therapy Facial Paralysis - etiology Female Headache - etiology Hearing Loss - etiology Hemifacial Spasm - etiology Humans Incidental Findings Internal Medicine Male Middle Aged Minnesota Neurilemmoma - diagnosis Neurilemmoma - therapy Paralysis Patient Outcome Assessment Retrospective Studies Schwann cells Tinnitus - etiology Young Adult |
| title | Facial Nerve Schwannomas: Review of 80 Cases Over 25 Years at Mayo Clinic |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T11%3A29%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Facial%20Nerve%20Schwannomas:%20Review%20of%2080%20Cases%20Over%2025%20Years%20at%20Mayo%20Clinic&rft.jtitle=Mayo%20Clinic%20proceedings&rft.au=Carlson,%20Matthew%20L.,%20MD&rft.date=2016-11-01&rft.volume=91&rft.issue=11&rft.spage=1563&rft.epage=1576&rft.pages=1563-1576&rft.issn=0025-6196&rft.eissn=1942-5546&rft.coden=MACPAJ&rft_id=info:doi/10.1016/j.mayocp.2016.07.007&rft_dat=%3Cgale_proqu%3EA472436773%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1837156544&rft_id=info:pmid/27720200&rft_galeid=A472436773&rft_els_id=1_s2_0_S0025619616304062&rfr_iscdi=true |